Isabella Samuelson

Isabella Samuelson

Auto-generated profile, based on publicly available information

Isabella Samuelson

Institute of Healthy Ageing & Department of Genetics, Evolution and Environment, University College London, London, WC1E 6BT, UK

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
SCStefania Carobbio
Stefania Carobbio
AGAnne-Claire Guénantin
Anne-Claire Guénantin
ISIsabella Samuelson
Isabella Samuelson
MBMyriam Bahri
Myriam Bahri
AVAntonio Vidal-Puig
Antonio Vidal-Puig

1 May 2018 in Essays in Biochemistry
Verified
Journal Article
Open access
PDF file
ISIsabella Samuelson
Isabella Samuelson
AVAntonio Vidal-Puig
Antonio Vidal-Puig
Extracellular vesicles (EVs) have emerged as a novel messaging system of the organism, mediating cell–cell and interorgan communication. Through their content of proteins and nucleic acids, as well as membrane proteins and lipid species, EVs can interact with and modulate the function of their target cells. The regulation of whole-body metabolism requires cross-talk between key metabolic tissues including adipose tissue (AT), the liver and skeletal muscle. Furthermore, the regulation of nutrient/energy allocation during pregnancy requires co-ordinated communication between the foetus and metabolic organs of the mother. A growing body of evidence is suggesting that EVs play a role in communication between and within key metabolic organs, both physiologically during metabolic homoeostasis but also contributing to pathophysiology during metabolic dysregulation observed in metabolic diseases such as obesity and diabetes. As obesity and its associated metabolic complications are reaching epidemic proportions, characterization of EV-mediated communication between key metabolic tissues may offer important insights into the regulation of metabolic functions during disease and offer global therapeutic opportunities. Here, we focus on the role of EVs in metabolic regulation and, in particular, EV-mediated cross-talk between cells of the AT.

4 April 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
CACaroline Araiz
Caroline Araiz
AYAnqi Yan
Anqi Yan
LBLucia Bettedi
Lucia Bettedi
ISIsabella Samuelson
Isabella Samuelson
SVSam Virtue
Sam Virtue
LFLazaros Foukas
Lazaros Foukas
The insulin/IGF-1 signalling pathway is a key regulator of metabolism and the rate of ageing. We previously documented that systemic inactivation of phosphoinositide 3-kinase (PI3K) p110α, the principal PI3K isoform that positively regulates insulin signalling, results in a beneficial metabolic effect in aged mice. Here we demonstrate that deletion of p110α specifically in the adipose tissue leads to less fat accumulation over a significant part of adult life and allows the maintenance of normal glucose tolerance despite insulin resistance. This effect of p110α inactivation is due to a potentiating effect on β-adrenergic signalling, which leads to increased catecholamine-induced energy expenditure in the adipose tissue. Our findings provide a paradigm of how partial inactivation of an essential component of the insulin signalling pathway can have an overall beneficial metabolic effect and suggest that PI3K inhibition could potentiate the effect of β-adrenergic agonists in the treatment of obesity and its associated comorbidities.

1 December 2019 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
SZShasha Zheng
Shasha Zheng
SGShanjun Guo
Shanjun Guo
GSGongrui Sun
Gongrui Sun
YSYanteng Shi
Yanteng Shi
ZWZhe Wei
Zhe Wei
XJXiaohong Jiang
Xiaohong Jiang
The global rise in obesity has become a public health crisis. During the onset of obesity, disrupted catecholamine signals have been described to contribute to excess fat accumulation, however, the molecular and metabolic change of subcutaneous adipose tissue (SAT) upon chronic high-fat feeding has rarely been investigated. Here, we show that chronic high-fat feeding caused a significant decrease in the expression of thermogenic genes and acquisition of partial deleterious features of visceral fat in SAT. Upregulated miR-149-3p was involved in this obesity-induced "visceralization" of SAT via inhibiting PRDM16, a master regulator that promoted SAT thermogenesis. Reduction of miR-149-3p significantly increased PRDM16 expression in SAT, with improved whole-body insulin sensitivity, decreased SAT inflammation, and liver steatosis in high-fat fed mice. These findings provided direct evidence of the anti-obese and anti-diabetic effect of PRDM16 in the obese background for the first time and identified that miR-149-3p could serve as a therapeutic target to protect against diet-induced obesity and metabolic dysfunctions.

21 February 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
CACaroline Araiz
Caroline Araiz
AYAnqi Yan
Anqi Yan
LBLucia Bettedi
Lucia Bettedi
ISIsabella Samuelson
Isabella Samuelson
SVSam Virtue
Sam Virtue
LFLazaros Foukas
Lazaros Foukas
An amendment to this paper has been published and can be accessed via a link at the top of the paper.

9 July 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SCStefania Carobbio
Stefania Carobbio
AGAnne-Claire Guenantin
Anne-Claire Guenantin
MBMyriam Bahri
Myriam Bahri
ISIsabella Samuelson
Isabella Samuelson
FHFloris Honig
Floris Honig
AVAntonio Vidal-Puig
Antonio Vidal-Puig
Increasing brown adipose tissue (BAT) mass and activation has been proposed as a potential therapeutic strategy to treat obesity and associated cardiometabolic complications. Given that obese and diabetic patients possess low amounts of BAT, an efficient way to expand their BAT mass would be necessary if BAT is to be useful. Currently, there is limited knowledge about how human BAT develops, differentiates, and is optimally activated. Moreover, to have access to human BAT is challenging, given its low volume and being anatomically dispersed. These constrain makes detailed mechanistic studies related to BAT development and function in humans virtually impossible. To overcome these limitations, we have developed a human-relevant new protocol for the differentiation of human pluripotent stem cells (hPSCs) into brown adipocytes (BAs). Unique to this protocol is that it is chemically-defined to recapitulate a physiological step-by-step developmental path of BAT that captures transient paraxial mesoderm and BAT progenitor states, on its way to reaching the adipocyte stage finally. These hPSC-derived BAs express brown adipocyte and thermogenic markers, are insulin sensitive, and respond to β-adrenergic stimuli. This new protocol is a scalable tool to study human BAs during development.